This clinical-stage biopharma targets neurological and psychiatric disorders with a pipeline of novel therapeutics advancing through trials.

Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) announced that it has entered into an agreement to expand the drug discovery collaboration agreement with ...

AbbVie is a Dividend King, poised for strong growth with Rinvoq and Skyrizi. Eli Lilly has taken control of the obesity drug market, with major possibilities ahead. Bristol Myers Squibb looks ready to ...

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) is among the 7 Cheap Pharmaceutical Stocks to Buy According to Hedge Funds. Collegium Pharmaceutical, Inc. (NASDAQ:COLL) is placed sixth on our list of ...

Ventavis® is an established inhaled prostacyclin analogue for the treatment of primary pulmonary hypertension Acquisition reinforces Essential Pharma’s mission to serve the needs of rare disease ...

ROCHESTER, N.Y. — Kodak is expanding its pharmaceutical offerings with the introduction of four new products. These products are variations of “phosphate buffered saline” and “water for injection,” ...

The makers of the upcoming Malayalam web series, Pharma, has finally dropped its trailer today (December 5). The video gives a glimpse into its plot as well as rest of the characters in this series, ...

Despite a cautious near-term market outlook, the portfolio manager highlights strong conviction in a portfolio built around pharma, diagnostics, hospitals, telecom and digital platforms like Yatra and ...

Pablo Legorreta, Founder, Chairman of the Board & CEO, reported "another successful quarter of execution on our goal to be the premier capital allocator in life sciences with consistent compounding ...

TEL AVIV, Israel, Oct. 24, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies ...

Viatris VTRS announced the acquisition of Tokyo-based Aculys Pharma, a clinical-stage biopharmaceutical company specializing in neurological therapies. The deal grants Viatris the rights to develop ...